venBio
Overview
venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs. They are mindful of potential acquisition partners from the outset, and they ensure that their companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
| Alumis Inc | Mar 2024 | Series C | - |
| Attovia Therapeutics | Apr 2025 | Series C | Co-investor |
| Artiva Biotherapeutics | Feb 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Richard Gaster
Managing Partner
Jaume Pons
Venbio Venture Partner
Yvonne Yamanaka
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is venBio based?
venBio is headquartered in San Francisco, California, United States.
When was venBio founded?
venBio was founded in 2011.
How many portfolio companies does venBio have?
venBio has 28 portfolio companies in Caplight's dataset.
What are some companies in venBio's portfolio?
Portfolio companies visible on Caplight include Parabilis Medicines, Fog Pharmaceuticals, Alumis Inc, Attovia Therapeutics, Artiva Biotherapeutics.
What was venBio's most recent investment shown here?
venBio's most recent investment in this portfolio sample was in Parabilis Medicines in 2026.
What sectors does venBio focus on?
venBio focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does venBio focus on?
venBio typically invests at the MultiStage stage.
What is venBio's AUM?
venBio's assets under management are estimated between $500.0M and $1.0B.